Back to FDA Applications sponsored by AMAG PHARMS INC

FDA Drug Application 022180 by AMAG PHARMS INC

Application Number022180
Application Type New Drug Application
Sponsor ApplicantAMAG PHARMS INC
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New ester, new salt, or other noncovalent derivative
Therapeutic Potential Standard
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP06/30/2009N22863000 7/2/2009
AP06/30/2009N22886000 7/7/2009
AP06/30/2009N24153000 11/25/2009
AP06/30/2009N24154000 11/25/2009
AP011/24/2010SLR27097003,022180s005ltr.pdf 11/30/2010
AP011/24/2010SLR27115003 12/1/2010
AP011/24/2010SLR27116005 12/1/2010
AP011/24/2010SLR27098005,022180s005ltr.pdf 11/30/2010
AP06/21/2011SLR29298006 6/28/2011
AP06/21/2011SLR29321006 6/29/2011
AP012/23/2013SCM38173010 12/24/2013
AP03/16/2015SLR42166011,022180Orig1s013ltr_corrected.pdf 3/17/2015
AP03/16/2015SLR42199011 3/19/2015
AP03/16/2015SLR42200013 3/19/2015
AP03/16/2015SLR42165013,022180Orig1s013ltr_corrected.pdf 3/17/2015

Back to FDA Applications sponsored by AMAG PHARMS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.